Cost-effectiveness of universal influenza vaccination in a pregnant population.

Full Abstract

OBJECTIVE:
The purpose of this study was to estimate whether universal influenza vaccination of pregnant women was cost-effective in the management of influenza-like illness during influenza season.

METHODS:
A decision analysis model was developed to investigate the cost-effectiveness of providing inactivated trivalent influenza vaccine to all pregnant women. This scenario was compared with providing supportive care only on a case-by-case basis to the unvaccinated pregnant population.

RESULTS:
Vaccination of 100% of pregnant women would save approximately 50 dollars per woman, resulting in a net gain of approximately 45 quality-adjusted hours relative to providing supportive care only.

CONCLUSION:
Universal vaccination with inactivated trivalent influenza vaccine is cost-saving relative to providing supportive care alone in the pregnant population.

LEVEL OF EVIDENCE:
III.

Learn Faster Today Improve your study skills

Author information

Author/s: Roberts, Scott (S); Hollier, Lisa M (LM); Sheffield, Jeanne (J); Laibl, Vanessa (V); Wendel, George D (GD);

Affiliation: Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9032, USA scott.roberts(-atsign-)utsouthwestern.edu

Journal and publication information

Publication Type: Journal Article

Journal: Obstetrics and gynecology (Obstet Gynecol), published in United States. (Language: eng)

Reference: 2006-Jun; vol 107 (issue 6) : pp 1323-9

Dates: Created 2006/06/01; Completed 2006/07/07;

PMID: 16738159, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Influenza Vaccines - economics; supply & distribution
Influenza, Human - economics; prevention & control
Monte Carlo Method
Orthomyxoviridae - immunology
Pregnancy
Pregnancy Complications, Infectious - economics; prevention & control
Quality-Adjusted Life Years

Associated Chemicals: Influenza Vaccines (0)

These are the highest related articles currently in the database:

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). 23 Apr 2003
Design of the Dutch prevention of influenza, surveillance and management (PRISMA) study. 31 Mar 2003
Race against time. 24 May 2005
Being prepared. Preparations for a pandemic of influenza. 29 Nov 2001
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). 10 Apr 2002
Immunization predictors in rural adults under 65 years of age. 30 Jan 2003
Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. 30 Dec 2004
Avian flu special: is this our best shot? 24 May 2005
Cost-effectiveness of influenza vaccination of healthy children. 5 Apr 2006
The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. 27 Feb 2007

See 100+ related articles.